Vaccines Global Market Report 2022 – By Type (Anti-Infective Vaccines, Autoimmunity, Others (Cancer And Others)), By Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines), By Route of Administration (Intramuscular (IM), Subcutaneous (SC), Oral, Others), By Valance (Monovalent, Multivalent), By Distribution Channel (Institutional Sale, Hospital Pharmacies, Retail Pharmacies) – Market Size, Trends, And Global Forecast 2022-2026

Starting Price : $5000.00 | Pages : 175 | Published : January 2022 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN

The vaccines market consists of sales of vaccines and related services. This industry includes establishments that produce anti-infective vaccines, autoimmunity vaccines and vaccines for cancer and other diseases. Vaccines create antibody-antigen reaction that helps in attaining resistance to the disease causing organism. Vaccines include recombinant vaccines, conjugate vaccines, live attenuated vaccines, inactivated vaccines, toxoid vaccines and others.  

The main types of vaccines market are anti-infective vaccines, autoimmunity, others (cancer and others). Anti-infective vaccines are used to prevent infectious diseases. The various technologies of vaccines include conjugate vaccines, inactivated and subunit vaccines, live attenuated vaccines, recombinant vaccines, and toxoid vaccines that are administered through intramuscular (IM), subcutaneous (SC), oral, and others. The different valance of vaccines market are monovalent and multivalent which are distributed by institutional sale, hospital pharmacies, and retail pharmacies.

The global vaccines market size is expected to decline from $92.70 billion in 2021 to $105.20 billion in 2022 at a compound annual growth rate (CAGR) of 13.5%. The slow decline is mainly due to the outbreak of COVID-19 that has led to deferment of immunocompromised treatments. The vaccines market is expected to reach $290.67 billion in 2026 at a CAGR of 28.9%.

Rising awareness on immunization and vaccination benefits in emerging markets is consistently driving the global vaccines market growth. World Health Organization (WHO) is taking initiatives to increase awareness of immunization through global vaccine action plan (GVAP) and global Immunization vision and strategy (GIVS). They aim to strengthen routine immunization, control morbidity and mortality from vaccine preventable diseases and help countries to immunize more people with a greater range of vaccines. The Organization accomplishes this work through its biological programme, the WHO Collaborating Centers, and the WHO Expert Committee on Biological Standardization (ECBS). In 2019, according to the WHO, approximately 85% of infants globally (116 million infants) received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine, protecting them against infectious diseases that can cause serious illness and disability or be fatal. Furthermore, 125 countries reached at least 90% coverage of the DTP3 vaccine in 2019.  

The vaccines market growth is limited due to severe shortage of skilled healthcare professionals for developing biologics drugs which requires specialized skillsets. These skillsets are limited to some research organizations and medical equipment companies in the USA and Europe, this is expected to be a major restraint on the market. According to a study conducted by the consulting firm Mercer, the United States will face significant healthcare worker shortages in the coming decade. The firm predicts a shortage of more than 400,000 home health aides and 29,400 nurse practitioners by 2025. This shortage also led to rise in competition and salaries for the limited talent pool available for biologics talent, thereby further limiting growth of the market.

The vaccines market has been witnessing multiple strategic initiatives and mergers and acquisitions in the recent years. Top companies in the market are strategically acquiring start-ups and mid-sized companies to broaden products and services. For instance, in February 2019, Bharat Biotech acquired Chiron Behring Vaccines, a clinical biotechnology company, one of the leading manufacturers of rabies vaccines across the globe. Similarly, in September 2021, Sanofi, a France based healthcare company, acquired Translate Bio, an mRNA therapeutics company developing potentially transformative medicines to treat diseases caused by protein or gene dysfunction, for a deal amount of $3.2 billion to develop mRNA vaccines. Companies in the industry are increasingly realigning their portfolios and pursuing profitable inorganic growth opportunities. Additionally, M&A interest is also being fueled by stronger corporate balance sheets, liquid debt markets, and continued favourable interest rates globally.

The Food and Drug Administration (FDA) is the National Regulatory Authority (NRA) in the United States responsible for assuring quality, safety, and effectiveness of all vaccines for human use. Center for Biologics Evaluation and Research (CBER) within the US FDA is responsible for regulating vaccines market. Governments across the world are encouraging the research and development of biologics in order to develop more targeted therapies and vaccines for various diseases. In May 2014, the US FDA announced a fast-track initiative to review its drugs and biologics policy to speed the availability of therapies to patients with serious conditions, orphan drugs for rare disease, while preserving the safety and efficacy standards. In 2016, FDA also removed a rule (Section 610.21 of the FDA code) which specified minimal potency limits for certain antibodies and antigens. In addition, FDA is also updating regulations (Section 610.53 of FDA code) regarding storage periods and storage conditions for biologics.  

In May 2020, Novavax, a US-based late-stage biotechnology company specialising in next-generation vaccines, announced the acquisition of Praha Vaccines, a subsidiary of the Cyrus Poonawalla Group, for a deal amount of $167 million. With this acquisition, Novavax increased its annual capacity of more than one billion doses of antigen for NVX-CoV2373, Novavax's COVID-19 vaccine candidate. Praha Vaccines was a subsidiary of the Cyrus Poonawalla Group, which is the parent company of Serum Institute of India and specialises in the production of immuno-biologicals.  

Major players in the vaccines market are AstraZeneca, Emergent Biosolutions, Glaxosmithkline, Merck, Pfizer, Sanofi Pasteur, Abbott, Astellas Pharma, Bavarian Nordic, CSL Limited, Daiichi Sankyo Company, Johnson & Johnson, Mitsubishi Tanabe Pharma Corporation, Serum Institute of India, Takeda Pharmaceutical Co. Ltd., Biological E Limited, BiondVax Pharmaceuticals Ltd, Bristol-Myers Squibb, Inovio Pharmaceuticals Inc., Madison Vaccines Incorporated, NOVARTIS AG, Novavax Inc., Panacea Biotec, Sinovac Biotech Ltd., Valneva SE, and VBI Vaccine Inc.

North America was the largest region in the vaccines market in 2021. The Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.  

The global vaccines market is segmented -

1) By Type: Anti-Infective Vaccines, Autoimmunity, Others (Cancer and Others)

2) By Technology: Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines

3) By Route of Administration: Intramuscular (IM), Subcutaneous (SC), Oral, Others

4) By Valence: Monovalent, Multivalent

5) By Distribution Channel: Institutional Sale, Hospital Pharmacies, Retail Pharmacies

    Table Of Contents

    1.Executive Summary

    2.Table Of Contents

    3.List Of Figures

    4.List Of Tables

    5.Report Structure

    6.Introduction And Market Characteristics

    6.1.General Market Definition

    6.2.Summary

    6.3.Vaccines Market Definition And Segmentations

    6.4.Market Segmentation By Type

    6.4.1.Anti-Infective Vaccines

    6.4.2.Anti-Cancer Vaccines

    6.4.3.Other Types

    6.5.Market Segmentation By Technology

    6.5.1.Conjugate Vaccines

    6.5.2.Inactivated And Subunit Vaccines

    6.5.3.Live Attenuated Vaccines

    6.5.4.Recombinant Vaccines

    6.5.5.Toxoid Vaccines

    6.5.6.Other Technologies

    6.6.Market Segmentation By Route Of Administration

    6.6.1.Intramuscular (IM)

    6.6.2.Subcutaneous (SC)

    6.6.3.Oral

    6.6.4.Other Route of Administration

    6.7.Market Segmentation By Valance

    6.7.1.Monovalent

    6.7.2.Multivalent

    6.8.Market Segmentation By Distribution Channel

    6.8.1.Hospital Pharmacies

    6.8.2.Retail Pharmacies

    6.8.3.Institutional Sales

    7.Major Market Trends

    7.1.Synthetic Biology In Vaccine Development

    7.2.Development Of Combination Vaccines

    7.3.Robust Research And Development

    7.4.Increasing Demand For Conjugate Vaccines

    7.5.Artificial Intelligence In Vaccine Development

    7.6.mRNA Vaccines

    7.7.Cancer Vaccines

    7.8.Increasing Acquisitions And Partnerships

    8.Global Market Size And Growth

    8.1.Market Size

    8.2.Historic Market Growth, 2016 – 2021, Value ($ Million)

    8.2.1.Market Drivers 2016 – 2021

    8.2.2.Market Restraints 2016 – 2021

    8.3.Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    8.3.1.Market Drivers 2021 – 2026

    8.3.2.Market Restraints 2021 – 2026

    9.Global Vaccines Market Segmentation

    9.1.Global Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    9.2.Global Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    9.3.Global Vaccines Market, Segmentation By Route Of Administration, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    9.4.Global Vaccines Market, Segmentation By Valence, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    9.5.Global Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    10.Vaccines Market, Regional and Country Analysis

    10.1.Global Vaccines Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    10.2.Global Vaccines Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.Asia-Pacific Market

    11.1.Summary

    11.2.Market Overview

    11.2.1.Region Information

    11.2.2.Market Information

    11.2.3.Background Information

    11.2.4.Government Initiatives

    11.2.5.Regulations

    11.2.6.Regulatory Bodies

    11.2.7.Major Associations

    11.2.8.Taxes Levied

    11.2.9.Corporate Tax Structure

    11.2.10.Investments

    11.2.11.Major Companies

    11.3.Asia-Pacific Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    11.4.Asia-Pacific Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    11.5.Asia-Pacific Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.6.Asia-Pacific Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.7.Asia-Pacific Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.8.Asia-Pacific Vaccines Market: Country Analysis

    11.9.China Market

    11.10.Summary

    11.11.Market Overview

    11.11.1.Country Information

    11.11.2.Market Information

    11.11.3.Background Information

    11.11.4.Government Initiatives

    11.11.5.Regulations

    11.11.6.Regulatory Bodies

    11.11.7.Major Associations

    11.11.8.Taxes Levied

    11.11.9.Corporate Tax Structure

    11.11.10.Investments

    11.11.11.Major Companies

    11.12.China Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    11.13.China Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    11.14.China Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.15.China Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.16.China Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.17.India Market

    11.18.India Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    11.19.India Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    11.20.India Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.21.India Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.22.India Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.23.Japan Market

    11.24.Japan Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    11.25. Japan Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    11.26. Japan Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.27. Japan Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.28. Japan Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.29. Australia Market

    11.30. Australia Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    11.31. Australia Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    11.32. Australia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.33. Australia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.34. Australia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.35. Indonesia Market

    11.36. Indonesia Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    11.37. Indonesia Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    11.38. Indonesia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.39. Indonesia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.40. Indonesia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.41. South Korea Market

    11.42. South Korea Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    11.43. South Korea Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    11.44. South Korea Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.45. South Korea Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.46. South Korea Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    12. Western Europe Market

    12.1. Summary

    12.2. Market Overview

    12.2.1. Region Information

    12.2.2. Market Information

    12.2.3. Background Information

    12.2.4. Government Initiatives

    12.2.5. Regulations

    12.2.6. Regulatory Bodies

    12.2.7. Major Associations

    12.2.8. Taxes Levied

    12.2.9. Corporate Tax Structure

    12.2.10. Investments

    12.2.11. Major Companies

    12.3. Western Europe Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    12.4. Western Europe Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    12.5. Western Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    12.6. Western Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    12.7. Western Europe Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    12.8. Western Europe Vaccines Market: Country Analysis

    12.9. UK Market

    12.10. UK Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    12.11. UK Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    12.12. UK Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    12.13. UK Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    12.14. UK Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    12.15. Germany Market

    12.16. Germany Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    12.17. Germany Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    12.18. Germany Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    12.19. Germany Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    12.20. Germany Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    12.21. France Market

    12.22. France Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    12.23. France Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    12.24. France Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    12.25. France Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    12.26. France Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    13. Eastern Europe Market

    13.1. Summary

    13.2. Market Overview

    13.2.1. Region Information

    13.2.2. Market Information

    13.2.3. Background Information

    13.2.4. Government Initiatives

    13.2.5. Regulations

    13.2.6. Regulatory Bodies

    13.2.7. Major Associations

    13.2.8. Taxes Levied

    13.2.9. Corporate Tax Structure

    13.2.10. Investments

    13.2.11. Major Companies

    13.3. Eastern Europe Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    13.4. Eastern Europe Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    13.5. Eastern Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    13.6. Eastern Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    13.7. Eastern Europe Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    13.8. Eastern Europe Vaccines Market: Country Analysis

    13.9. Russia Market

    13.10. Russia Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    13.11. Russia Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    13.12. Russia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    13.13. Russia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    13.14. Russia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    14. North America Market

    14.1. Summary

    14.2. Market Overview

    14.2.1. Region Information

    14.2.2. Market Information

    14.2.3. Background Information

    14.2.4. Government Initiatives

    14.2.5. Regulations

    14.2.6. Regulatory Bodies

    14.2.7. Major Associations

    14.2.8. Taxes Levied

    14.2.9. Corporate Tax Structure

    14.2.10. Investments

    14.2.11. Major Companies

    14.3. North America Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    14.4. North America Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    14.5. North America Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    14.6. North America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    14.7. North America Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    14.8. North America Vaccines Market: Country Analysis

    14.9. USA Market

    14.10. Summary

    14.11. Market Overview

    14.11.1. Country Information

    14.11.2. Market Information

    14.11.3. Background Information

    14.11.4. Government Initiatives

    14.11.5. Regulations

    14.11.6. Regulatory Bodies

    14.11.7. Major Associations

    14.11.8. Taxes Levied

    14.11.9. Corporate Tax Structure

    14.11.10. Investments

    14.11.11. Major Companies

    14.12. USA Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    14.13. USA Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    14.14. USA Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    14.15. USA Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    14.16. USA Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    15. South America Market

    15.1. Summary

    15.2. Market Overview

    15.2.1. Region Information

    15.2.2. Market Information

    15.2.3. Background Information

    15.2.4. Government Initiatives

    15.2.5. Regulations

    15.2.6. Regulatory Bodies

    15.2.7. Major Associations

    15.2.8. Taxes Levied

    15.2.9. Corporate Tax Structure

    15.2.10. Investments

    15.2.11. Major Companies

    15.3. South America Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    15.4. South America Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    15.5. South America Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    15.6. South America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    15.7. South America Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    15.8. South America Vaccines Market: Country Analysis

    15.9. Brazil Market

    15.10. Brazil Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    15.11. Brazil Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    15.12. Brazil Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    15.13. Brazil Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    15.14. Brazil Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    16. Middle East Market

    16.1. Summary

    16.2. Market Overview

    16.2.1. Region Information

    16.2.2. Market Information

    16.2.3. Background Information

    16.2.4. Government Initiatives

    16.2.5. Regulations

    16.2.6. Regulatory Bodies

    16.2.7. Major Associations

    16.2.8. Taxes Levied

    16.2.9. Corporate Tax Structure

    16.2.10. Investments

    16.2.11. Major Companies

    16.3. Middle East Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    16.4. Middle East Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    16.5. Middle East Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    16.6. Middle East Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    16.7. Middle East Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    17. Africa Market

    17.1. Summary

    17.2. Market Overview

    17.2.1. Region Information

    17.2.2. Market Information

    17.2.3. Background Information

    17.2.4. Government Initiatives

    17.2.5. Regulations

    17.2.6. Regulatory Bodies

    17.2.7. Major Associations

    17.2.8. Taxes Levied

    17.2.9. Corporate Tax Structure

    17.2.10. Investments

    17.2.11. Major Companies

    17.3. Africa Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    17.4. Africa Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    17.5. Africa Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    17.6. Africa Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    17.7. Africa Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    18. Competitive Landscape and Company Profiles

    19. Company Profiles

    19.1. Pfizer Inc

    19.1.1. Company Overview

    19.1.2. Products And Services

    19.1.3. Business Strategy

    19.1.4. Financial Overview

    19.2. Merck & Co., Inc

    19.2.1. Company Overview

    19.2.2. Products And Services

    19.2.3. Business Strategy

    19.2.4. Financial Overview

    19.3. GlaxoSmithKline plc

    19.3.1. Company Overview

    19.3.2. Products And Services

    19.3.3. Business Strategy

    19.3.4. Financial Overview

    19.4. Sanofi S.A

    19.4.1. Company Overview

    19.4.2. Products And Services

    19.4.3. Business Strategy

    19.4.4. Financial Overview

    19.5. AstraZeneca plc

    19.5.1. Company Overview

    19.5.2. Products And Services

    19.5.3. Business Strategy

    19.5.4. Financial Overview

    20. Pipeline Analysis

    21. Key Mergers And Acquisitions

    21.1. GSK plc Acquired Affinivax Inc

    21.2. Ceva Santé Animale Acquired Artemis Technologies Inc.

    21.3. Pfizer Inc. Acquired ReViral Ltd.

    21.4. NEC OncoImmunity AS Acquired Vaximm AG’s Neoantigen Vaccine Development Assets.

    21.5. Sanofi S.A. To Acquire Origimm Biotechnology GmbH

    21.6. Vaccitech plc Acquired Avidea Technologies, Inc.

    21.7. Shanghai Fosun Pharmaceutical Co., Ltd. Acquired Chengdu Antejin Biotech Co. Ltd.

    21.8. Sanofi S.A. Acquired Translate Bio, Inc.

    21.9. Thermo Fisher Scientific Inc. Acquired Viral Vector Manufacturing Business from Novasep SAS

    21.10. Merck KGaA’s Life Sciences Company MilliporeSigma Acquired AmpTec

    21.11. Sanofi S.A. Acquired Kymab Ltd

    21.12. BioNTech SE Acquired GMP Certified Manufacturing Site of Novartis AG

    21.13. GlaxoSmithKline plc Acquired 10% Stake In CureVac For $163.67 million

    21.14. Merck & Co., Inc. Acquired Themis Bioscience GmbH

    21.15. Novavax, Inc. Acquired Praha Vaccines For $167 million

    21.16. Bavarian Nordic A/S Acquired Global Rights for Two Vaccines from GSK For $940.07 Million

    21.17. Bharat Biotech International Limited Acquired Chiron Behring Vaccines from GlaxoSmithKline

    22. Global Vaccines Market Opportunities And Strategies

    22.1. Global Vaccines Market In 2026 – Countries Offering Most New Opportunities

    22.2. Global Vaccines Market In 2026 – Segments Offering Most New Opportunities

    22.3. Global Vaccines Market In 2026 – Growth Strategies

    22.3.1. Market Trend Based Strategies

    22.3.2. Competitor Strategies

    23. Vaccines Market, Conclusions And Recommendations

    23.1. Conclusions

    23.2.Recommendations

    23.2.1.Product

    23.2.2.Place

    23.2.3.Price

    23.2.4.Promotion

    23.2.5.People

    24.Appendix

    24.1.Market Data Sources

    24.2.Research Methodology

    24.3.Currencies

    24.4.The Business Research Company

    24.5.Copyright and Disclaimer

List Of Tables

    Table 1: Global Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 2: Global Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 3: Global Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 4: Global Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 5: Global Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 6: Global Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 7: Global Vaccines Market, Segmentation By Route Of Administration, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 8: Global Vaccines Market, Segmentation By Route Of Administration, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 9: Global Vaccines Market, Segmentation By Valence, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 10: Global Vaccines Market, Segmentation By Valence, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 11: Global Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 12: Global Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 13: Global Vaccines Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 14: Global Vaccines Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 15: Global Vaccines Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 16: Global Vaccines Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 17: Asia-Pacific GDP Per Capita, By Country, 2016-2021, $
  • Table 18: Asia-Pacific Population By Age Group, By Country, 2016-2026, Thousands
  • Table 19: Asia-Pacific Public Healthcare Expenditure, By Country, 2015-2020, $ Billion
  • Table 20: Asia-Pacific Private Healthcare Expenditure, By Country, 2015-2020, $ Billion
  • Table 21: Asia-Pacific Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 22: Asia-Pacific Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 23: Asia-Pacific Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 24: Asia-Pacific Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 25: Asia-Pacific Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 26: Asia-Pacific Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 27: Asia-Pacific Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 28: Asia-Pacific Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 29: China GDP Per Capita, 2016-2021, $
  • Table 30: China Population By Age Group, 2016-2026, Thousands
  • Table 31: China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 32: China Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 33: China Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 34: China Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 35: China Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 36: China Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 37: China Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 38: China Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 39: China Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 40: India Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 41: India Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 42: India Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 43: India Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 44: India Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 45: India Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 46: India Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 47: India Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 48: Japan Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 49: Japan Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 50: Japan Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 51: Japan Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 52: Japan Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 53: Japan Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 54: Japan Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 55: Japan Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 56: Australia Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 57: Australia Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 58: Australia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 59: Australia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 60: Australia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 61: Australia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 62: Australia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 63: Australia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 64: Indonesia Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 65: Indonesia Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 66: Indonesia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 67: Indonesia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 68: Indonesia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 69: Indonesia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 70: Indonesia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 71: Indonesia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 72: South Korea Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 73: South Korea Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 74: South Korea Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 75: South Korea Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 76: South Korea Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 77: South Korea Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 78: South Korea Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 79: South Korea Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 80: Western Europe GDP Per Capita, By Country, 2016-2021, $
  • Table 81: Western Europe Population By Age Group, By Country, 2016-2026, Thousands
  • Table 82: Western Europe Public Healthcare Expenditure, By Country, 2015-2020, $ Billion
  • Table 83: Western Europe Private Healthcare Expenditure, By Country, 2015-2020, $ Billion
  • Table 84: Western Europe Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 85: Western Europe Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 86: Western Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 87: Western Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 88: Western Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 89: Western Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 90: Western Europe Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 91: Western Europe Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 92: UK Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 93: UK Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 94: UK Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 95: UK Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 96: UK Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 97: UK Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 98: UK Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 99: UK Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 100: Germany Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 101: Germany Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 102: Germany Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 103: Germany Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 104: Germany Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 105: Germany Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 106: Germany Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 107: Germany Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 108: France Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 109: France Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 110: France Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 111: France Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 112: France Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 113: France Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 114: France Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 115: France Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 116: Eastern Europe GDP Per Capita, By Country, 2016-2021, $
  • Table 117: Eastern Europe Population By Age Group, By Country, 2016-2026, Thousands
  • Table 118: Eastern Europe Public Healthcare Expenditure, By Country, 2015-2020, $ Billion
  • Table 119:  Eastern Europe Private Healthcare Expenditure, By Country, 2015-2020, $ Billion
  • Table 120: Eastern Europe Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 121: Eastern Europe Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 122: Eastern Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 123: Eastern Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 124: Eastern Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 125: Eastern Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 126: Eastern Europe Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 127: Eastern Europe Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 128: Russia Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 129: Russia Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 130: Russia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 131: Russia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 132: Russia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 133: Russia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 134: Russia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 135: Russia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 136: North America GDP Per Capita, By Country, 2016-2021, $
  • Table 137: North America Population By Age Group, By Country, 2016-2026, Thousands
  • Table 138: North America Public Healthcare Expenditure, By Country, 2015-2020, $ Billion
  • Table 139: North America Private Healthcare Expenditure, By Country, 2015-2020, $ Billion
  • Table 140: North America Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 141: North America Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 142: North America Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 143: North America Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 144: North America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 145: North America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 146: North America Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 147: North America Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 148: USA GDP Per Capita, 2016-2021, $
  • Table 149: USA Population By Age Group, 2016-2026, Thousands
  • Table 150: USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 151: USA Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 152: USA Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 153: USA Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 154: USA Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 155: USA Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 156: USA Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 157: USA Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 158: USA Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 159: South America GDP Per Capita, By Country, 2016-2021, $
  • Table 160: South America Population By Age Group, By Country, 2016-2026, Thousands
  • Table 161: South America Public Healthcare Expenditure, By Country, 2015-2020, $ Billion
  • Table 162: South America Private Healthcare Expenditure, By Country, 2015-2020, $ Billion
  • Table 163: South America Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 164: South America Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 165: South America Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 166: South America Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 167: South America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 168: South America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 169: South America Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 170: South America Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 171: Brazil Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 172: Brazil Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 173: Brazil Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 174: Brazil Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 175: Brazil Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 176: Brazil Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 177: Brazil Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 178: Brazil Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 179: Middle East GDP Per Capita, By Country, 2016-2021, $
  • Table 180: Middle East Population By Age Group, By Country, 2016-2026, Thousands
  • Table 181: Middle East Public Healthcare Expenditure, By Country, 2015-2020, $ Billion
  • Table 182: Middle East Private Healthcare Expenditure, By Country, 2015-2020, $ Billion
  • Table 183: Middle East Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 184: Middle East Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 185: Middle East Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 186: Middle East Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 187: Middle East Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 188: Middle East Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 189: Middle East Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 190: Middle East Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 191: Africa GDP Per Capita, By Country, 2016-2021, $
  • Table 192: Africa Population By Age Group, By Country, 2016-2026, Thousands
  • Table 193: Africa Public Healthcare Expenditure, By Country, 2015-2020, $ Billion
  • Table 194: Africa Private Healthcare Expenditure, By Country, 2015-2020, $ Billion
  • Table 195: Africa Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 196: Africa Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 197: Africa Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 198: Africa Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 199: Africa Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 200: Africa Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 201: Africa Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 202: Africa Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 203: Vaccines Market, Key Competitor Estimated Market Shares, 2021, Percentage (%)
  • Table 204: Pfizer – Financial Performance, 2017– 2021, $ Billion
  • Table 205: Merck & Co – Financial Performance, 2017– 2021, $ Billion
  • Table 206: GlaxoSmithKline – Financial Performance, 2017 - 2021, $ Billion
  • Table 207: Sanofi – Financial Performance, 2017– 2021, $ Billion
  • Table 208: AstraZeneca – Financial Performance, 2017– 2021, $ Billion
  • Table 209: Global Vaccine Market, Product Pipeline Analysis
  • Table 210: Global Vaccines Market Size Gain ($ Million), 2021 – 2026, By Country
  • Table 211: Global Vaccines Market Size Gain ($ Million), Segmentation By Type, 2021 – 2026
  • Table 212: Global Vaccines Market Size Gain ($ Million), Segmentation By Technology, 2021 – 2026
  • Table 213: Global Vaccines Market Size Gain ($ Million), Segmentation By Route Of Administration, 2021 – 2026
  • Table 214: Global Vaccines Market Size Gain ($ Million), Segmentation By Valence, 2021 – 2026
  • Table 215: Global Vaccines Market Size Gain ($ Million), Segmentation By Distribution Channel, 2021 – 2026
  • Table 216: Vaccines Market Data Sources

List Of Figures

    Figure 1: Global Vaccines Market Segmentation By Type
  • Figure 2: Global Vaccines Market Segmentation By Technology
  • Figure 3: Global Vaccines Market Segmentation By Route of Administration
  • Figure 4: Global Vaccines Market Segmentation By Valance
  • Figure 5: Global Vaccines Market Segmentation By Distribution Channel
  • Figure 6: Global Vaccines Market, Historic, 2015 – 2020, $ Million
  • Figure 7: Global Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 8: Global Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 9: Global Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 10: Global Vaccines Market, Segmentation By Route of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 11: Global Vaccines Market, Segmentation By Valance, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 12: Global Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 13: Global Vaccines Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 14: Global Vaccines Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 15: Asia-Pacific Vaccines Market, Historic, 2015 – 2020, $ Million
  • Figure 16: Asia-Pacific Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 17: Asia-Pacific Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 18: Asia-Pacific Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 19: China Vaccines Market, Historic, 2015 – 2020, $ Million
  • Figure 20: China Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 21: China Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 22: China Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 23: India Vaccines Market, Historic, 2015 – 2020, $ Million
  • Figure 24: India Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 25: India Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 26: India Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 27: Japan Vaccines Market, Historic, 2015 – 2020, $ Million
  • Figure 28: Japan Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 29: Japan Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 30: Japan Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 31: Australia Vaccines Market, Historic, 2015 – 2020, $ Million
  • Figure 32: Australia Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 33: Australia Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 34: Australia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 35: Indonesia Vaccines Market, Historic, 2015 – 2020, $ Million
  • Figure 36: Indonesia Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 37: Indonesia Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 38: Indonesia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 39: South Korea Vaccines Market, Historic, 2015 – 2020, $ Million
  • Figure 40: South Korea Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 41: South Korea Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 42: South Korea Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 43: Western Europe Vaccines Market, Historic, 2015 – 2020, $ Million
  • Figure 44: Western Europe Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 45: Western Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 46: Western Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 47: UK Vaccines Market, Historic, 2015 – 2020, $ Million
  • Figure 48: UK Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 49: UK Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 50: UK Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 51: Germany Vaccines Market, Historic, 2015 – 2020, $ Million
  • Figure 52: Germany Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 53: Germany Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 54: Germany Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 55: France Vaccines Market, Historic, 2015 – 2020, $ Million
  • Figure 56: France Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 57: France Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 58: France Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 59: Eastern Europe Vaccines Market, Historic, 2015 – 2020, $ Million
  • Figure 60: Eastern Europe Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 61: Eastern Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 62: Eastern Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 63: Russia Vaccines Market, Historic, 2015 – 2020, $ Million
  • Figure 64: Russia Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 65: Russia Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 66: Russia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 67: North America Vaccines Market, Historic, 2015 – 2020, $ Million
  • Figure 68: North America Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 69: North America Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 70: North America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 71: USA Vaccines Market, Historic, 2015 – 2020, $ Million
  • Figure 72: USA Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 73: USA Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 74: USA Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 75: South America Vaccines Market, Historic, 2015 – 2020, $ Million
  • Figure 76: South America Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 77: South America Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 78: South America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 79: Brazil Vaccines Market, Historic, 2015 – 2020, $ Million
  • Figure 80: Brazil Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 81: Brazil Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 82: Brazil Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 83: Middle East Vaccines Market, Historic, 2015 – 2020, $ Million
  • Figure 84: Middle East Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 85: Middle East Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 86: Middle East Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 87: Africa Vaccines Market, Historic, 2015 – 2020, $ Million
  • Figure 88: Africa Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 89: Africa Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 90: Africa Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 91: Global Vaccines Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
  • Figure 92: GlaxoSmithKline plc – Financial Performance, 2016 – 2020, $ Billion
  • Figure 93: Merck & Co., Inc. – Financial Performance, 2016 – 2020, $ Billion
  • Figure 94: Sanofi S.A. – Financial Performance, 2016 – 2020, $ Billion
  • Figure 95: Pfizer Inc. – Financial Performance, 2016 – 2020, $ Billion
  • Figure 96: CSL Limited – Financial Performance, 2016 – 2020, $ Billion
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report